X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Pfizer with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ADCOCK INGRAM (S. Africa) - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PFIZER   ADCOCK INGRAM
EQUITY SHARE DATA
    PFIZER
Mar-18
ADCOCK INGRAM
Jun-14
PFIZER/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs2,365367-   
Low Rs1,625265-   
Sales per share (Unadj.) Rs430.3109.1-  
Earnings per share (Unadj.) Rs78.7-27.5-  
Cash flow per share (Unadj.) Rs93.2-22.8-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs586.585.7-  
Shares outstanding (eoy) m45.75168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.62.9 160.2%   
Avg P/E ratio x25.3-11.5 -220.8%  
P/CF ratio (eoy) x21.4-13.9 -154.5%  
Price / Book Value ratio x3.43.7 92.3%  
Dividend payout %25.40-   
Avg Mkt Cap Rs m91,27153,291 171.3%   
No. of employees `0002.64.3 61.3%   
Total wages/salary Rs m3,1433,345 94.0%   
Avg. sales/employee Rs Th7,484.84,290.3 174.5%   
Avg. wages/employee Rs Th1,195.0779.1 153.4%   
Avg. net profit/employee Rs Th1,369.1-1,081.1 -126.6%   
INCOME DATA
Net Sales Rs m19,68518,418 106.9%  
Other income Rs m1,143129 886.1%   
Total revenues Rs m20,82818,547 112.3%   
Gross profit Rs m5,003-3,192 -156.7%  
Depreciation Rs m663795 83.3%   
Interest Rs m4499 0.8%   
Profit before tax Rs m5,479-4,357 -125.8%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,878272 690.0%   
Profit after tax Rs m3,601-4,641 -77.6%  
Gross profit margin %25.4-17.3 -146.7%  
Effective tax rate %34.3-6.2 -548.7%   
Net profit margin %18.3-25.2 -72.6%  
BALANCE SHEET DATA
Current assets Rs m24,16713,490 179.1%   
Current liabilities Rs m9,5447,590 125.7%   
Net working cap to sales %74.332.0 231.9%  
Current ratio x2.51.8 142.5%  
Inventory Days Days55111 49.7%  
Debtors Days Days29124 23.2%  
Net fixed assets Rs m9,5147,863 121.0%   
Share capital Rs m45886 535.0%   
"Free" reserves Rs m26,3750-   
Net worth Rs m26,83214,456 185.6%   
Long term debt Rs m255,080 0.5%   
Total assets Rs m36,90027,309 135.1%  
Interest coverage x1,305.5-7.7 -16,884.4%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.50.7 79.1%   
Return on assets %9.8-15.2 -64.4%  
Return on equity %13.4-32.1 -41.8%  
Return on capital %20.4-19.8 -103.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,4660-   
CASH FLOW
From Operations Rs m3,3181,572 211.0%  
From Investments Rs m-2,383-483 493.7%  
From Financial Activity Rs m-1,1044,611 -23.9%  
Net Cashflow Rs m-1695,700 -3.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.06 Rs / ZAR

Compare PFIZER With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PFIZER With: VENUS REMEDIES  PLETHICO PHARMA  ABBOTT INDIA  SUN PHARMA  DR. DATSONS LABS  



Today's Market

Sensex Ends 274 Points Lower; IT and Energy Stocks Witness Selling(Closing)

Share markets in India continued to witness selling pressure during closing hours and ended their trading session on a negative note.

Related Views On News

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY19); Net Profit Up 60.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, PFIZER has posted a net profit of Rs 918 m (up 60.6% YoY). Sales on the other hand came in at Rs 5 bn (up 18.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Nov 21, 2018 (Close)

TRACK PFIZER

PFIZER - VENUS REMEDIES COMPARISON

COMPARE PFIZER WITH

MARKET STATS